Nursing · Independent exam preparation
Neurovascular Registered Nurse (NVRN-BC) Preparation Guide Study Guide
Practise stroke assessment, imaging choices, reperfusion decisions and complication prevention with a focused NVRN-BC guide, original questions and recall cards.
By CertMedbry · Updated 28 October 2026
Learn to distinguish disabling neurological deficits, interpret complementary imaging findings, recognise deterioration and connect stroke mechanisms with treatment and prevention. This selective 60-concept guide covers all eight NVRN-BC domains in approximate blueprint proportions. The official issuer-linked outline remains the full examination scope; the clinical topics here are educational selections within its broad headings.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which credential and professional level does this guide address?
This guide addresses the Neurovascular Registered Nurse (NVRN-BC) certification for registered nurses. The workbook label “Neurocritical Care Registered Nurse” is inaccurate for this exact designation; the official evidence does not establish a historical name change or a separate examination under that label. NVRN-BC should not be treated as a nurse practitioner examination or substituted for the separately listed ANVP, ASC or CNIC certifications.
Certification for Neurovascular Registered Nurse (NVRN-BC) · NVC-3
How many examination questions are verified, and how many are scored?
The official blueprint states that test-item allocations use a 200-question basis. The supplied issuer evidence does not distinguish scored questions from unscored or pretest questions. The 20 questions in this guide are a separate learning set and should not be interpreted as a complete examination form.
What duration, delivery method, adaptivity and item styles are established?
The supplied NVC-3 page displays a 2026 in-person examination schedule. It does not establish the complete range of delivery arrangements, examination duration, adaptive testing status or actual item styles. This guide uses independent four-option, single-best-answer drills; that educational format does not establish the format of the certification examination.
Which blueprint version applies to this guide?
The guide follows the current issuer-linked NVRN Exam Blueprint documented on October 28, 2026, consistent with the October 11, 2026 evidence. The blueprint is undated and gives no revision number or effective date. A 2026 examination schedule or website footer does not establish a blueprint effective date. The outline supplies domain headings and weights, rather than a detailed subtopic syllabus.
How does the official blueprint distribute content?
The allocations are Assessment of Acute Clinical Neurovascular Findings 18.5%; Diagnosis of Acute Neurovascular Disease 18%; Acute Neurovascular Management 14%; Pathophysiology & Pathogenesis of Neurovascular Disease 14%; Secondary Stroke Prevention 10%; Complication Avoidance & Management 9%; Research Support for Acute Neurovascular Practice 9%; and Stroke Systems of Care 7.5%. The concepts, questions and cards approximate these proportions while covering every domain.
What eligibility and jurisdiction information is verified?
The official NVRN page specifies registered-nurse licensure in the applicant’s country of origin and evidence of at least 1,000 hours of acute stroke clinical care in the immediately preceding 12 months. It lists several qualifying activities and describes a supervisor-signature alternative for applicants below that threshold. Certification does not itself establish nursing licensure or practice authority in another jurisdiction.
How should learners use clinical recommendations from different jurisdictions?
The clinical references support assessment techniques, mechanisms and treatment principles; they do not expand the official examination outline. Canadian, British and American recommendations should be read with their stated populations and dates. British Columbia transport guidance supports examples of coordinated triage and notification, while its destination rules remain regional. Treatment eligibility and operational pathways require the applicable current clinical protocol.
Emergency Department Evaluation and Management of Patients with Transient Ischemic Attack and Acute Stroke · National Clinical Guideline for Stroke: Acute Care · Pre-hospital Triage and Transport Guidelines for Adult Stroke in British Columbia
NVRN-BC is the Neurovascular Registered Nurse credential offered through the Neurovascular Clinicians Certification Corporation (NVC-3). It concerns acute neurovascular nursing care of hospitalised stroke patients. This independently authored guide, question set and flashcards are educational materials, without issuer endorsement or a claim to reproduce examination items.
Outline used: Current issuer-linked, undated NVRN Exam Blueprint, retrieved 2026-10-11; no revision number or effective date stated. The workbook label 'Neurocritical Care Registered Nurse' maps to the officially named Neurovascular Registered Nurse credential through the exact NVRN-BC designation. The assigned slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Assessment of Acute Clinical Neurovascular Findings18.5%
1.How do aphasia and dysarthria differ?
Aphasia disrupts language formulation or comprehension, whereas dysarthria disrupts the motor production of speech. Assess naming, comprehension and meaningful language separately from articulation. A patient may pronounce words unclearly while selecting correct words and following commands, supporting dysarthria. Incorrect naming, impaired comprehension or disordered meaningful expression supports aphasia. The NIH Stroke Scale assesses language and dysarthria separately because either can occur alone or together.
Apply it
A patient follows a two-step command and names familiar objects correctly, but every response sounds slurred. Document impaired articulation, assess the remaining neurological findings and avoid assuming that unclear speech proves impaired language comprehension.
Common pitfall: Judging language solely by how speech sounds can misclassify dysarthria as aphasia. Hearing impairment, intubation and language differences also require attention during assessment.
2.What distinguishes extinction from a primary sensory deficit?
Extinction occurs when a patient detects a stimulus presented alone but fails to acknowledge it during simultaneous bilateral stimulation. This pattern reflects impaired attention to competing information rather than complete loss of the affected sensory pathway. Test each side separately before bilateral stimulation. Assess visual fields and primary sensation independently so that a field defect or sensory loss is not mistaken for extinction. Inattention can involve more than one sensory modality.
Apply it
A patient identifies touch on either hand when tested separately. During simultaneous touching of both hands, the patient reports only the right hand. Record left tactile extinction and investigate associated attentional deficits rather than documenting complete left sensory loss.
Common pitfall: Testing only simultaneous stimulation hides whether the patient can detect either stimulus individually. Establish intact single-sided detection before interpreting a response as extinction.
3.How is last-known-well time established?
Last-known-well is the latest time the patient was known to be at their neurological baseline. It differs from the time symptoms were discovered, the emergency call time and hospital arrival. For symptoms found on awakening, bedtime may establish last-known-well if normal function was confirmed then. Record the source and certainty of the history. An unknown onset does not automatically exclude treatment because selected patients may qualify through imaging-based pathways.
Apply it
A spouse confirms normal conversation at 22:15. At 06:40, the patient awakens with weakness. Record 22:15 as last-known-well and 06:40 as symptom discovery, then communicate both times during urgent stroke evaluation and handoff.
Common pitfall: Using awakening or ambulance arrival as onset falsely shortens the apparent interval. An uncertain timeline should remain explicitly uncertain rather than becoming an invented exact time.
Pre-hospital Triage and Transport Guidelines for Adult Stroke in British Columbia · Emergency Department Evaluation and Management of Patients with Transient Ischemic Attack and Acute Stroke
4.Why is immediate glucose assessment essential?
Hypoglycaemia can cause focal weakness, abnormal speech or altered consciousness and therefore mimic acute stroke. Immediate glucose measurement identifies a rapidly reversible contributor without replacing neurological assessment or brain imaging. Correct an abnormal result promptly and reassess the neurological findings. Persistent focal deficits require continued stroke evaluation because hypoglycaemia and stroke can coexist. Hyperglycaemia also matters clinically, but an elevated glucose result does not establish the cause of a focal deficit.
Apply it
A patient develops unilateral weakness and has a markedly low bedside glucose result. Treat the glucose abnormality immediately and repeat the neurological examination. If weakness persists after correction, continue the urgent stroke pathway without assuming the diagnosis is resolved.
Common pitfall: Stopping the stroke evaluation after finding low glucose can miss concurrent ischaemia. Clinical improvement and residual focal findings must both inform the next decision.
5.How should arm drift be assessed consistently?
The NIH Stroke Scale arm assessment uses a standard position and observation period to distinguish drift from more severe weakness. Position the arm at 90 degrees when sitting or 45 degrees when supine, with palms down, and observe for 10 seconds. Score the observed ability to maintain position, including whether the limb reaches the bed. Standardisation makes changes more interpretable than informal comparisons of grip strength alone.
Apply it
A supine patient initially holds the left arm at 45 degrees, then lowers it before 10 seconds without touching the bed. Describe the observed drift and apply the scale’s corresponding category rather than substituting a grip-strength estimate.
Common pitfall: Changing position or observation time between examinations can create an apparent neurological change. Grip strength alone does not reproduce the standard arm motor assessment.
6.How does standard leg testing reveal motor change?
The NIH Stroke Scale leg motor item assesses each leg in the supine position at approximately 30 degrees for five seconds. Observe whether the leg remains elevated, drifts, reaches the bed or shows no movement. Testing each leg separately helps identify asymmetry and serial change. The shorter observation period and lower angle differ from arm testing. Document relevant physical limitations because pain or a pre-existing impairment can affect performance.
Apply it
A patient previously maintained the right leg above the bed for five seconds. On reassessment, it falls immediately despite the same positioning and instructions. Report the new motor deterioration and assess accompanying neurological and physiological changes promptly.
Common pitfall: Applying the arm’s 10-second interval to the leg changes the test. Compare examinations performed with consistent technique and distinguish chronic limitations from new weakness.
7.When does poor coordination represent limb ataxia?
Limb ataxia is incoordination that exceeds what weakness alone explains. The NIH Stroke Scale uses finger-to-nose and heel-to-shin testing with the eyes open, considering visual limitations when necessary. A paralysed limb cannot demonstrate coordination failure independently of paralysis, so inability to perform the movement does not automatically earn an ataxia score. Evaluate motor strength and coordination separately, and use the scale’s specific instructions for untestable physical conditions.
Apply it
A patient cannot lift a profoundly weak arm to perform finger-to-nose testing. The opposite arm and both legs show no incoordination. Record the weakness under motor assessment rather than assigning ataxia solely because the weak arm cannot complete the task.
Common pitfall: Equating every failed coordination task with cerebellar dysfunction inflates ataxia findings. The decisive feature is incoordination beyond the limitation caused by motor weakness.
8.How are gaze abnormalities assessed at the bedside?
The NIH Stroke Scale gaze item evaluates horizontal eye movements rather than visual acuity or visual fields. Observe spontaneous alignment and assess the ability to look horizontally, using the prescribed voluntary or reflexive approach when communication is limited. A gaze preference and a fixed deviation are not equivalent findings. Record what movement is possible instead of inferring the score from head position, apparent neglect or the patient’s willingness to follow a verbal instruction alone.
Apply it
A patient’s eyes rest toward the right but move across the midline when appropriately tested. Document the observed range of eye movement and evaluate attention and visual fields separately instead of describing the resting preference as fixed gaze deviation.
Common pitfall: Confusing eye position with visual field loss combines different neurological functions. Poor comprehension may limit command following without proving that horizontal eye movement is absent.
9.How should command performance be interpreted?
Command performance depends on comprehension, attention and the physical ability to execute the requested action. The NIH Stroke Scale provides standard commands and permits appropriate substitution when a limb cannot be used. Its instructions also distinguish an unequivocal attempt limited by weakness from a failure to understand. Assess the patient’s actual response using the item’s rules, and avoid treating an immobile hand as evidence of reduced consciousness or global inability to follow commands.
Apply it
A patient with a paralysed right hand clearly attempts the requested action and follows the eye command. Apply the item’s instructions and use an appropriate functional alternative when needed, while recording the motor deficit independently.
Common pitfall: Repeatedly choosing an action the patient physically cannot perform confounds motor disability with comprehension. Standard commands and permitted substitutions preserve the meaning of the assessment.
10.Why do serial neurological findings matter more than an isolated total?
A neurological score summarises findings at one moment, while serial examinations reveal direction and speed of change. Compare individual components, consciousness, pupils and relevant physiological observations rather than relying only on the total. Different deficits can produce the same numerical score. New weakness, declining alertness or worsening headache requires prompt reassessment for evolving ischaemia, haemorrhage or another complication. Consistent technique and a documented baseline make changes easier to recognise and communicate.
Apply it
A patient’s total score is unchanged, but language has improved while alertness has worsened. Communicate the new consciousness change explicitly, repeat focused observations and escalate assessment rather than reporting that the examination is simply stable.
Common pitfall: An unchanged total can conceal a clinically important exchange between component findings. Medication effects and glucose abnormalities also require consideration when interpreting deterioration.
National Clinical Guideline for Stroke: Acute Care · NIH Stroke Scale
11.Why can a low stroke score conceal substantial disability?
A low NIH Stroke Scale total does not establish that a deficit is nondisabling. Aphasia, loss of useful hand function or deficits affecting walking can profoundly limit everyday activities despite a modest score. Assess the actual functional consequence, previous abilities and current examination. The 2026 acute ischaemic stroke guidance emphasises disabling deficits in reperfusion decisions. Numerical severity supports communication but cannot replace a focused judgement about what the patient can no longer do.
Apply it
A previously independent patient has isolated language impairment and a low total score but cannot communicate basic needs. Describe that functional loss during urgent reperfusion evaluation instead of presenting the low number as evidence that treatment is unnecessary.
Common pitfall: Calling a stroke minor solely from its score can obscure a disabling deficit. Disability assessment must address meaningful function rather than score size alone.
Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS
Diagnosis of Acute Neurovascular Disease18%
12.What does urgent noncontrast CT establish?
Urgent noncontrast head CT helps distinguish intracranial haemorrhage from a presentation compatible with ischaemic stroke and can reveal other structural causes of symptoms. This distinction changes immediate treatment because therapies intended to restore arterial flow can be hazardous in active bleeding. CT also provides information about established tissue injury. Its initial purpose is not to prove every early ischaemic lesion; clinical findings and further imaging may remain necessary despite an unrevealing scan.
Apply it
A patient arrives with sudden hemiparesis and severe headache. Obtain urgent brain imaging before selecting stroke-specific antithrombotic or reperfusion treatment, because symptoms alone cannot reliably distinguish an arterial occlusion from an intracranial haemorrhage.
Common pitfall: Assuming headache proves haemorrhage or absent headache proves ischaemia substitutes a symptom pattern for imaging. Either stroke type can produce overlapping neurological findings.
National Clinical Guideline for Stroke: Acute Care · Stroke Diagnosis — NHLBI
13.Why does a normal early CT not exclude ischaemic stroke?
Early ischaemic tissue changes may be subtle or absent on noncontrast CT, especially with small lesions or difficult anatomical locations. A scan without haemorrhage therefore answers an urgent safety question without necessarily explaining the deficit. Persistent focal symptoms still require a clinical stroke assessment and appropriate vascular or magnetic resonance imaging. Interpret the scan together with symptom timing and examination rather than equating a normal report with normal cerebral perfusion.
Apply it
A patient has persistent aphasia shortly after sudden onset, but the initial CT shows no haemorrhage or visible infarction. Continue time-sensitive stroke evaluation and vascular assessment rather than reassuring the patient that the normal CT rules out stroke.
Common pitfall: Waiting for an infarct to become visible can waste an opportunity for treatment. Early CT sensitivity and the urgency of excluding bleeding are different issues.
14.How does CT angiography change the diagnostic question?
CT angiography evaluates arterial anatomy and patency, helping identify an occluded major artery or clinically important stenosis. Noncontrast CT chiefly characterises brain findings and excludes haemorrhage; it does not provide the same vessel assessment. Detecting a large-vessel occlusion can trigger thrombectomy evaluation and transfer planning. The decision depends on the vascular lesion together with clinical findings and tissue imaging, rather than an angiographic abnormality considered in isolation.
Apply it
A patient has a severe focal deficit and no haemorrhage on noncontrast CT. Urgent angiography demonstrates an intracranial arterial occlusion, giving the team information needed to evaluate endovascular treatment and organise transfer if that service is unavailable locally.
Common pitfall: Treating noncontrast CT as a complete vascular study can miss a treatable occlusion. A vessel abnormality also requires correlation with the presenting neurological syndrome.
15.What does diffusion-weighted MRI reveal?
Diffusion-weighted MRI detects restricted water movement associated with acute ischaemic cellular injury and can identify lesions that are not apparent on early CT. It is particularly useful when lesion size or location makes diagnosis difficult. The finding must be interpreted with the clinical presentation and other MRI sequences because restricted diffusion is not exclusive to arterial infarction. Greater sensitivity does not mean that every acute stroke will immediately produce a visible diffusion lesion.
Apply it
A patient has a persistent focal syndrome and an unrevealing CT. MRI demonstrates a small diffusion-restricting lesion matching the examination, strengthening the diagnosis of acute infarction while the team continues investigation of its vascular or cardiac mechanism.
Common pitfall: Treating diffusion restriction as a complete diagnosis ignores other possible causes and the need for clinical correlation. MRI lesion detection does not itself determine stroke mechanism.
National Clinical Guideline for Stroke: Acute Care · Stroke Diagnosis — NHLBI
16.When can a negative diffusion MRI be misleading?
A negative diffusion-weighted MRI does not invariably exclude acute ischaemic stroke. Very early imaging, small infarcts and posterior circulation lesions can produce an initially negative study. Persistent compatible findings require continued clinical consideration, review of imaging limitations and sometimes repeat or complementary imaging. The appropriate conclusion is that no lesion was demonstrated on that examination, rather than that the patient’s focal neurological syndrome has been disproved.
Apply it
A patient has persistent diplopia, gait instability and a focal brainstem examination, but an early diffusion MRI is negative. Continue specialist stroke assessment and appropriate vascular evaluation instead of assigning a benign diagnosis solely from the scan.
Common pitfall: Allowing one negative image to override a convincing evolving examination can delay diagnosis. Imaging timing and lesion location influence how strongly a negative result should reassure.
17.How can imaging support treatment when onset is unknown?
DWI-positive/FLAIR-negative mismatch means an ischaemic lesion is visible on diffusion-weighted MRI without corresponding clear FLAIR hyperintensity, suggesting relatively recent injury despite uncertain clock time. Core-perfusion mismatch instead compares the estimated established infarct core with a larger hypoperfused region, suggesting potentially salvageable tissue. The 2026 AHA/ASA guidance supports advanced-imaging selection for intravenous thrombolysis in selected unknown-onset presentations and selected presentations 4.5–9 hours after onset. These thrombolysis pathways have distinct selection criteria from thrombectomy, which additionally requires an eligible arterial occlusion and treatment-specific clinical and imaging findings.
Apply it
A patient awakens with disabling aphasia. Preserve the actual last-known-well and discovery times. A DWI-positive/FLAIR-negative lesion can support an MRI-selected thrombolysis assessment; a favourable core-perfusion mismatch supports a different tissue-selection approach. Separately assess vessel imaging for thrombectomy eligibility.
Common pitfall: DWI-FLAIR mismatch is a tissue-timing pattern, whereas core-perfusion mismatch estimates threatened tissue beyond the core. Neither finding alone guarantees treatment or establishes eligibility for both thrombolysis and thrombectomy.
Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS
18.Why is ECG important during stroke investigation?
An ECG can identify atrial fibrillation and other cardiac abnormalities relevant to stroke mechanism and immediate care. Atrial fibrillation supports consideration of a cardiac embolic source because ineffective atrial contraction promotes thrombus formation. A single normal tracing does not exclude intermittent atrial fibrillation. Obtain cardiac assessment without unnecessarily delaying urgent brain imaging or reperfusion decisions, and distinguish documenting a rhythm from proving that it caused the current event.
Apply it
A patient’s admission ECG shows atrial fibrillation after an ischaemic stroke. Communicate the finding for mechanism assessment and prevention planning while the acute team separately determines reperfusion eligibility and the appropriate timing of later antithrombotic treatment.
Common pitfall: A normal ECG is a brief sample of rhythm, not proof that paroxysmal atrial fibrillation is absent. Conversely, detected atrial fibrillation still requires clinical interpretation.
Stroke Diagnosis — NHLBI · Top Things to Know: 2021 Secondary Stroke Prevention Guideline
19.Which anticoagulant details change acute treatment assessment?
Acute stroke assessment requires the anticoagulant’s exact name, last dose, dosing pattern and relevant laboratory or renal information. Warfarin and direct oral anticoagulants cannot be evaluated with identical assumptions. A routine normal INR does not reliably establish absence of a direct oral anticoagulant effect. Medication history influences bleeding risk and reperfusion eligibility, so corroborate uncertain information using available medication records or a reliable witness while the time-sensitive evaluation proceeds.
Apply it
A patient reports taking a blood thinner but cannot name it. A family medication list identifies apixaban taken that morning. Communicate the drug and timing explicitly; a normal INR should not be presented as proof that anticoagulant activity is absent.
Common pitfall: Recording only “on anticoagulation” omits decision-critical information. Treating INR as a universal anticoagulant screen can produce unsafe conclusions about direct oral anticoagulants.
20.How do ECG and echocardiography answer different questions?
ECG records cardiac electrical activity and can reveal an arrhythmia such as atrial fibrillation. Echocardiography evaluates cardiac structure and function and may identify a potential source of embolism. These tests provide complementary information rather than interchangeable results. A normal rhythm tracing does not exclude structural cardiac disease, and a structural abnormality does not automatically establish causation. Select and interpret cardiac investigations in relation to the stroke pattern and clinical history.
Apply it
A patient has an ischaemic stroke with no atrial fibrillation on the initial ECG, but the team remains concerned about a cardiac source. Explain that echocardiography assesses different potential causes and is not made redundant by the normal tracing.
Common pitfall: Assuming that one normal cardiac test excludes every cardiac mechanism confuses electrical rhythm with structural assessment. An incidental abnormality also requires evidence linking it to the event.
21.Why should vascular imaging include the relevant arterial pathway?
Stroke mechanism assessment often requires examination of both intracranial vessels and arteries supplying the brain from the neck. An extracranial carotid lesion can produce downstream embolism even when the visible infarction lies inside the brain. Identifying the location and severity of disease helps distinguish potential mechanisms and prevention options. A brain image showing infarction does not by itself identify the responsible artery or establish whether a stenosis is causally related.
Apply it
A patient has a new hemispheric infarct. Head and neck vascular imaging identifies ipsilateral carotid narrowing, prompting assessment of whether the lesion is symptomatic and whether carotid intervention should form part of the secondary prevention plan.
Common pitfall: Stopping investigation after locating the infarct leaves its source unresolved. A stenosis on the opposite side or in an unrelated territory may be incidental.
Emergency Department Evaluation and Management of Patients with Transient Ischemic Attack and Acute Stroke · Top Things to Know: 2021 Secondary Stroke Prevention Guideline
22.When does neurological deterioration require renewed imaging?
New neurological deterioration after a stroke can reflect haemorrhage, infarct progression, swelling, hydrocephalus or a physiological disturbance. Reassess airway, vital signs, glucose and the neurological examination promptly while escalating for urgent medical review and appropriate repeat imaging. A previously reassuring scan describes an earlier moment and cannot exclude a new complication. The diagnostic task is to identify the cause of change quickly, rather than attributing all deterioration to the original deficit.
Apply it
After an initially stable period, a stroke patient develops worsening headache, vomiting and reduced alertness. Initiate urgent reassessment and escalation for repeat brain imaging while checking physiological causes, instead of waiting for the next scheduled neurological observation.
Common pitfall: Attributing reduced alertness to fatigue without reassessment can miss a treatable complication. An earlier scan does not remain reassuring when the examination has materially changed.
Acute Neurovascular Management14%
23.When should a low-score stroke still receive thrombolysis evaluation?
A low neurological severity score should not prevent thrombolysis evaluation when the deficit is disabling and other eligibility requirements are met. Disability depends on the functional consequence, such as inability to communicate, walk or use a hand meaningfully. The 2026 guidance distinguishes disabling deficits from mild nondisabling presentations. Nurses support the decision by documenting precise deficits, timing, baseline function, glucose, medication exposure and imaging readiness rather than using a score threshold as a substitute for assessment.
Apply it
A patient within the standard treatment window has isolated but disabling aphasia and no haemorrhage on CT. Escalate complete thrombolysis eligibility assessment and describe the communication loss clearly, even though the total neurological score is low.
Common pitfall: Equating low score with nondisabling stroke can deny appropriate assessment. Eligibility still requires consideration of timing, bleeding risk, imaging and other treatment criteria.
Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS
24.What distinguishes alteplase and tenecteplase in acute stroke care?
Both agents activate plasminogen to promote fibrin clot breakdown. Alteplase for acute ischaemic stroke uses an initial intravenous bolus of 10% of the total dose over one minute, followed by the remaining 90% infused over 60 minutes. Tenecteplase uses a single intravenous bolus over five seconds. The 2026 AHA/ASA guidance supports either agent for eligible patients within 4.5 hours after onset. This guideline recommendation differs from the supplied US alteplase label dated 2018 and tenecteplase label dated 2025, which each specify initiation within three hours; a guideline recommendation does not itself change product labeling.
Apply it
A stroke treatment order changes from alteplase to tenecteplase before administration. Reconcile the selected drug’s complete order, preparation and bolus administration instructions. Remove the previous alteplase infusion instructions and distinguish the applicable guideline pathway from the cited product label’s treatment window.
Common pitfall: Alteplase requires a bolus followed by an infusion; tenecteplase requires a single bolus. Exchanging their administration instructions or importing a regimen from another indication risks medication error.
Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS · 103172s5259lbl.pdf · 103909s5197lbl.pdf
25.How has thrombectomy selection moved beyond a simple small-core rule?
Thrombectomy eligibility depends on the occluded artery, clinical severity, time and imaging. A concrete expanded indication in the 2026 AHA/ASA guidance is a strong recommendation for thrombectomy in basilar artery occlusion presenting within 24 hours with NIHSS at least 10. This recommendation concerns basilar occlusion with that severity threshold, rather than every posterior circulation occlusion. Separately, selected patients with larger established infarct cores can benefit under the applicable large-core criteria; neither a large core nor its absence alone determines eligibility.
Apply it
A patient presents 12 hours after onset with CTA-confirmed basilar artery occlusion and NIHSS 14. Recognise the time, artery and severity as matching the stated recommendation and activate urgent thrombectomy assessment. Evaluate a patient with a large anterior circulation core under the separate criteria for that population.
Common pitfall: The basilar recommendation cannot be extended automatically to every vertebral or posterior cerebral artery occlusion, or to all patients with NIHSS below 10. Large-core eligibility also remains a separate clinical and imaging decision.
Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS
26.Why can intensive blood pressure lowering after thrombectomy be harmful?
Blood pressure management after thrombectomy must balance haemorrhagic risk against adequate cerebral perfusion. The 2026 guidance advises against routine intensive systolic lowering below 140 mm Hg after endovascular treatment, including after complete reperfusion. Successful reopening of an artery does not prove that aggressive reduction is beneficial. Monitor pressure and neurological status closely, avoid unsupported targets and apply the appropriate postprocedure protocol while communicating clinically significant changes promptly.
Apply it
After successful thrombectomy, a proposed routine order seeks systolic pressure below 140 mm Hg for every patient. Request review against current guidance and the patient’s clinical circumstances while continuing monitoring and implementing the confirmed treatment plan.
Common pitfall: Assuming lower pressure always means less bleeding ignores perfusion-related harm. The caution against an intensive target does not mean abandoning blood pressure monitoring or treatment.
Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS
27.Why should blood pressure control in intracerebral haemorrhage be smooth?
In spontaneous intracerebral haemorrhage, carefully controlled blood pressure reduction can reduce ongoing vascular stress while avoiding large fluctuations and excessive falls. The 2022 guidance emphasises smooth, sustained control with limited variability. Decisions depend on haemorrhage severity, presenting pressure and the clinical situation; one aggressive target does not fit every patient. Nursing care links accurate measurement, ordered treatment, frequent reassessment and prompt reporting of hypotension or neurological change.
Apply it
A patient with intracerebral haemorrhage has repeated pressure surges followed by sharp drops after treatment. Report the variability and review the delivery plan with the team, aiming for consistent control rather than responding only to isolated peak readings.
Common pitfall: Chasing each reading with abrupt treatment changes can increase variability. Smooth control requires attention to the trend and clinical response, not simply the lowest achievable number.
Top Things to Know: 2022 Spontaneous Intracerebral Hemorrhage Guideline
28.When does cerebellar haemorrhage require urgent surgical escalation?
Cerebellar intracerebral haemorrhage can compress the brainstem or obstruct cerebrospinal fluid flow within the confined posterior fossa. The 2022 AHA/ASA guideline recommends immediate surgical evacuation, with or without external ventricular drainage, to reduce mortality when any indication is present: neurological deterioration, brainstem compression, hydrocephalus from ventricular obstruction or cerebellar haematoma volume at least 15 mL. The volume threshold is an independent indication; deterioration or compression need not develop first. Ventricular drainage alone may be insufficient because it does not remove the posterior fossa haematoma.
Apply it
A patient remains alert but has a cerebellar haematoma measuring 16 mL. Escalate immediately for neurosurgical evacuation assessment without waiting for reduced consciousness. Deterioration, compression or obstructive hydrocephalus also demands immediate escalation even when the measured volume is smaller.
Common pitfall: Waiting for deterioration overlooks the independent volume indication. Treating hydrocephalus with drainage alone may leave dangerous brainstem compression from the haematoma unresolved.
Top Things to Know: 2022 Spontaneous Intracerebral Hemorrhage Guideline
29.How should an intracerebral haemorrhage prognostic score be used?
A baseline severity score can standardise communication and describe population-level prognosis after intracerebral haemorrhage. It cannot determine an individual patient’s outcome with certainty. The 2022 guidance cautions against using such a score as the sole basis for limiting life-sustaining treatment. Decisions require the evolving clinical course, reversible problems, the patient’s values and shared discussion. Early pessimistic treatment limitation can also influence the outcomes later attributed to the original injury.
Apply it
A family is told that a high haemorrhage score guarantees death. Clarify that the score communicates severity rather than certainty, support discussion of the patient’s preferences and ensure decisions consider the evolving examination and available treatment options.
Common pitfall: Turning a prognostic estimate into an automatic withdrawal rule confuses group risk with individual certainty. A numerical score cannot replace informed shared decision-making.
Top Things to Know: 2022 Spontaneous Intracerebral Hemorrhage Guideline
30.How should thrombolysis and thrombectomy assessment proceed together?
Intravenous thrombolysis and thrombectomy address reperfusion through different methods and require parallel eligibility assessment when both may apply. Planning endovascular treatment should not create avoidable delay in otherwise indicated intravenous treatment. Likewise, giving a thrombolytic does not remove the need to identify a large-vessel occlusion or arrange thrombectomy evaluation. Nurses help coordinate imaging, medication checks, time documentation and transfer communication so that one pathway does not unnecessarily obstruct the other.
Apply it
A patient appears eligible for intravenous thrombolysis and has a large-vessel occlusion requiring transfer. Coordinate the approved thrombolytic plan and transfer preparations concurrently, communicating treatment status and timing to the receiving team rather than waiting to complete one entire pathway first.
Common pitfall: Assuming that transfer planning replaces intravenous eligibility assessment can create avoidable delay. Giving a thrombolytic also does not justify waiting to assess a treatable occlusion.
Emergency Department Evaluation and Management of Patients with Transient Ischemic Attack and Acute Stroke · Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS
Pathophysiology & Pathogenesis of Neurovascular Disease14%
31.What distinguishes an embolus from local thrombosis?
An embolus travels from its site of origin and lodges in a downstream vessel, whereas local thrombosis forms at the site of obstruction. A cardiac thrombus or material from an upstream arterial plaque can embolise to the brain. Atherosclerotic disease can also promote thrombosis directly at a narrowed segment. Distinguishing the likely mechanism matters because prevention may target a cardiac source, diseased artery or another cause rather than treating all arterial occlusions identically.
Apply it
A patient with atrial fibrillation develops an abrupt cerebral arterial occlusion without a matching local plaque explanation. Consider a cardiac embolic mechanism during investigation, while recognising that identifying atrial fibrillation alone does not prove the source beyond doubt.
Common pitfall: Using thrombosis and embolism as exact synonyms hides where the obstruction originated. The same final arterial blockage can arise through mechanisms requiring different prevention strategies.
32.How do infarct core and ischaemic penumbra differ?
The infarct core represents tissue with severe, established ischaemic injury, while the penumbra is hypoperfused tissue that may remain viable if blood flow is restored. Their relative sizes change over time and depend partly on collateral circulation. Reperfusion aims to preserve threatened tissue rather than reverse every established lesion. Imaging estimates these compartments imperfectly, so treatment selection combines tissue information with the clinical syndrome, vessel status and the applicable evidence-based pathway.
Apply it
Imaging shows an arterial occlusion with a region of severely injured tissue surrounded by a larger region of reduced perfusion. Explain that the threatened surrounding tissue provides a potential treatment opportunity, while the established core limits what reperfusion can recover.
Common pitfall: Assuming all hypoperfused tissue is already dead removes the rationale for reperfusion. Assuming all abnormal tissue is salvageable overstates the benefit treatment can provide.
Stroke — NIH Health · Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS
33.Why do patients progress at different rates after arterial occlusion?
An arterial occlusion reduces direct blood supply, but alternative vascular routes may continue delivering some flow to threatened tissue. Better collateral circulation can slow progression from reversible dysfunction to infarction; poor collateral flow can permit rapid injury. Consequently, equal elapsed times do not guarantee equal tissue damage. Time remains urgent because collateral support is limited and may fail, while imaging helps determine the tissue state in selected treatment pathways.
Apply it
Two patients arrive after similar symptom intervals with comparable arterial occlusions but different amounts of established injury. Interpret the difference as compatible with variable tissue perfusion and collateral support, rather than assuming one timeline must necessarily be inaccurate.
Common pitfall: Using favourable imaging as permission to delay treatment ignores ongoing tissue risk. Variable progression explains differing opportunities, but it does not make elapsed time unimportant.
Stroke — NIH Health · Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS
34.How does intracerebral haemorrhage injure the brain?
Intracerebral haemorrhage places blood directly within brain tissue, disrupting local structures and producing pressure effects. Haematoma expansion, surrounding swelling and ventricular extension can worsen injury after the initial event. Obstruction of cerebrospinal fluid flow may produce hydrocephalus. This evolving mechanism explains why serial consciousness, neurological and physiological observations are essential even after diagnosis. The amount, location and progression of bleeding all matter; initial size alone does not describe the complete risk.
Apply it
A patient with a known haemorrhage becomes progressively less alert despite no new external injury. Consider evolving bleeding, swelling or hydrocephalus as possible mechanisms and escalate assessment rather than assuming the original haematoma has completed its effects.
Common pitfall: Viewing haemorrhage as a single completed event underestimates secondary deterioration. Location and ventricular involvement can be clinically important even when total blood volume appears limited.
Stroke — NIH Health · Top Things to Know: 2022 Spontaneous Intracerebral Hemorrhage Guideline
35.Why can an arteriovenous malformation bleed?
An arteriovenous malformation contains abnormal connections between arteries and veins that bypass a normal capillary network. The altered vessel architecture and flow can predispose the lesion to rupture and intracranial bleeding. An underlying vascular malformation therefore represents a different mechanism from chronic small-vessel arteriopathy. Recognising this distinction supports appropriate vascular investigation after haemorrhage, particularly when the presentation or imaging suggests an underlying structural vascular cause.
Apply it
A patient with intracranial haemorrhage has imaging that suggests a cluster of abnormal vessels. Explain why further vascular characterisation may be needed instead of assuming that the bleeding mechanism is established solely because the patient also has hypertension.
Common pitfall: A common risk factor does not exclude a structural lesion. Finding hypertension should not end investigation when haemorrhage features raise concern for a vascular malformation.
Stroke Causes and Risk Factors — NHLBI · Top Things to Know: 2022 Spontaneous Intracerebral Hemorrhage Guideline
36.What makes cerebral amyloid angiopathy a haemorrhage mechanism?
Cerebral amyloid angiopathy involves amyloid deposition in cerebral vessel walls, weakening affected vessels and increasing haemorrhage risk. It is an important mechanism of lobar intracerebral bleeding, particularly in older adults. Its distribution differs from the typical deep pattern associated with hypertensive arteriopathy, although imaging location alone is not definitive. Recognising the suspected mechanism matters when discussing recurrence risk and later decisions about treatments that alter bleeding or thrombotic risk.
Apply it
An older patient has recurrent lobar haemorrhages. Recognise cerebral amyloid angiopathy as a relevant mechanism for specialist assessment and prevention discussions, rather than automatically assigning the pattern to the same small-vessel process associated with deep hypertensive bleeding.
Common pitfall: Calling every haemorrhage hypertensive obscures clinically important mechanisms. Conversely, older age and a single lobar bleed do not establish cerebral amyloid angiopathy with certainty.
Top Things to Know: 2022 Spontaneous Intracerebral Hemorrhage Guideline
37.How does hypertensive arteriopathy contribute to deep haemorrhage?
Chronic hypertension can damage small penetrating cerebral arteries, making them susceptible to rupture. This arteriopathy is associated with haemorrhage in deep structures, although blood pressure measured during an acute event does not by itself prove the underlying cause. Acute stress and brain injury can also elevate pressure. Mechanism assessment combines prior history, haemorrhage distribution and appropriate investigation, while long-term blood pressure management remains important for reducing future vascular risk.
Apply it
A patient with longstanding poorly controlled hypertension develops a deep intracerebral haemorrhage. Connect the history and anatomical pattern to possible small-vessel arteriopathy while supporting further evaluation and planning sustained blood pressure management after the acute phase.
Common pitfall: An elevated emergency blood pressure is not a complete causal diagnosis. Avoid overlooking another mechanism simply because acute hypertension accompanies the neurological emergency.
Stroke Causes and Risk Factors — NHLBI · Top Things to Know: 2022 Spontaneous Intracerebral Hemorrhage Guideline
38.How do intracerebral and subarachnoid haemorrhage differ anatomically?
Intracerebral haemorrhage occurs within the brain tissue, whereas subarachnoid haemorrhage occurs in the space surrounding the brain where cerebrospinal fluid circulates. These locations influence the pattern of injury, diagnostic investigation and subsequent management. A haemorrhage can extend between compartments, so the categories are not always isolated in an individual patient. Precise imaging terminology matters because the word haemorrhagic stroke alone does not communicate the full anatomical problem.
Apply it
A report describes blood predominantly in the subarachnoid spaces rather than a parenchymal haematoma. Preserve that anatomical distinction in handoff and care planning instead of summarising every intracranial bleed as an identical intracerebral haemorrhage.
Common pitfall: Using intracerebral and intracranial as interchangeable terms loses anatomical precision. Blood location should come from imaging, not from headache severity or symptom description alone.
Secondary Stroke Prevention10%
39.Why does atrial fibrillation usually change antithrombotic selection?
Atrial fibrillation can promote atrial thrombus formation and subsequent cerebral embolism. For many patients with ischaemic stroke and atrial fibrillation, oral anticoagulation is the appropriate preventive strategy when there is no contraindication. Antiplatelet treatment does not provide an equivalent substitute for this mechanism. The choice and timing of anticoagulation require consideration of bleeding risk, infarct characteristics and other clinical factors, rather than an automatic decision to begin treatment immediately after every stroke.
Apply it
A stroke patient is found to have atrial fibrillation and has no established contraindication to anticoagulation. Ensure prevention planning addresses an anticoagulant strategy and its timing rather than assuming that aspirin alone fully addresses the identified embolic risk.
Common pitfall: Correct drug class does not determine immediate timing. Acute infarct size, haemorrhagic risk and other clinical circumstances still influence when an anticoagulant can safely begin.
Top Things to Know: 2021 Secondary Stroke Prevention Guideline
40.Which antithrombotic principle applies to noncardioembolic stroke?
For noncardioembolic ischaemic stroke, antiplatelet therapy generally addresses arterial platelet-mediated thrombosis more appropriately than routine anticoagulation. Prevention should follow the established or likely mechanism rather than the fact that a clot was present somewhere in the circulation. Most patients do not require combined anticoagulant and antiplatelet therapy solely for secondary stroke prevention. A separate cardiac or vascular indication may change the plan, so medication reconciliation must include why each agent is prescribed.
Apply it
A patient has an atherosclerotic ischaemic stroke without atrial fibrillation or another anticoagulant indication. Review the proposed antiplatelet prevention plan and ask for clarification if anticoagulation is suggested solely because the event involved an arterial clot.
Common pitfall: Assuming every clot requires anticoagulation ignores stroke mechanism. Adding multiple antithrombotic classes without a clear indication can increase bleeding without a corresponding preventive benefit.
Top Things to Know: 2021 Secondary Stroke Prevention Guideline
41.When is dual antiplatelet therapy a limited strategy?
Canadian Stroke Best Practices recommends aspirin plus clopidogrel for 21 days after an eligible acute noncardioembolic minor ischaemic stroke with NIHSS 0–3 or a high-risk TIA when bleeding risk is not high, followed by antiplatelet monotherapy. It separately describes three months of aspirin plus clopidogrel within the SAMMPRIS approach for selected recent stroke or TIA attributable to symptomatic 70–99% intracranial atherosclerotic stenosis and low estimated bleeding risk. Duration follows the indication and regimen; dual therapy is not routine lifelong prevention.
Apply it
For an eligible minor stroke without another indication for prolonged dual therapy, document the 21-day aspirin–clopidogrel course and subsequent monotherapy. For a recent event caused by symptomatic 80% intracranial stenosis, recognise that the selected three-month regimen also accompanies intensive lipid, blood pressure and lifestyle management.
Common pitfall: Extending every minor-stroke regimen to three months increases bleeding exposure without establishing added benefit. Ending every dual regimen at 21 days can also overlook a separate qualifying indication such as severe symptomatic intracranial stenosis.
Top Things to Know: 2021 Secondary Stroke Prevention Guideline · 6. Antiplatelet Therapy for Ischemic Stroke and Transient Ischemic Attack | Canadian Stroke Best Practices
42.Why does symptomatic carotid stenosis require timely assessment?
A carotid stenosis is symptomatic when it plausibly caused a recent event in the corresponding arterial territory. Selected patients with severe ipsilateral extracranial carotid disease may benefit from revascularisation as well as medical prevention. Suitability depends on neurological status, stenosis characteristics, procedural risk and other patient factors. Identifying a stenosis therefore creates a need for timely specialist assessment; it does not establish that every narrowing requires a procedure.
Apply it
A patient has a nondisabling hemispheric stroke and severe narrowing of the ipsilateral carotid artery. Ensure prompt specialist assessment of revascularisation suitability alongside medical prevention rather than treating the lesion as an incidental finding requiring only routine distant follow-up.
Common pitfall: A carotid narrowing is not automatically symptomatic merely because a stroke occurred. The side, vascular territory, severity and patient’s procedural suitability all influence interpretation.
Top Things to Know: 2021 Secondary Stroke Prevention Guideline
43.How should vascular risk modification become an actionable plan?
Secondary prevention combines mechanism-specific treatment with sustained management of modifiable vascular risks. Blood pressure, lipids, diabetes, tobacco exposure, physical activity and dietary patterns require individual assessment rather than a generic instruction to live more healthily. Identify a measurable action, barriers and follow-up responsibility for each relevant problem. Behaviour change and medication adherence often need repeated multidisciplinary support. An effective plan connects the patient’s circumstances with practical actions that can continue after discharge.
Apply it
A patient misses antihypertensive doses because the regimen conflicts with work and prescription access is unreliable. Bring these barriers into discharge planning, coordinate a feasible regimen and access plan, and establish who will review blood pressure and adherence.
Common pitfall: Repeating advice without addressing cost, access or understanding may leave risk unchanged. Adherence problems require investigation before assuming that a preventive medication has failed.
Top Things to Know: 2021 Secondary Stroke Prevention Guideline
44.Why should an unexplained embolic stroke prompt investigation rather than automatic anticoagulation?
An embolic-appearing stroke without an established source does not automatically justify empirical anticoagulation. The 2021 guidance advises against treating embolic stroke of uncertain source with anticoagulants solely on that classification. Continued investigation may reveal intermittent atrial fibrillation or another actionable cause. Rhythm monitoring can be useful when no alternative cause has been identified. Prevention should follow the evidence for the diagnosed condition rather than treating an unconfirmed mechanism as if it were established.
Apply it
A patient has an embolic-appearing infarct but no detected atrial fibrillation or other definite source. Support further mechanism investigation and indicated rhythm monitoring rather than telling the patient that an embolic imaging pattern alone mandates anticoagulation.
Common pitfall: An embolic pattern suggests a mechanism but does not identify its source. Empirical anticoagulation can add bleeding risk without the expected benefit in an unselected unexplained-stroke group.
Top Things to Know: 2021 Secondary Stroke Prevention Guideline
Complication Avoidance & Management9%
45.When must swallowing be screened before oral intake?
Stroke patients should undergo an appropriate swallowing screen before receiving food, fluids or oral medications. Stroke can impair airway protection even when the patient is alert and requests a drink. A failed screen requires withholding oral intake and arranging further assessment with a safe route for essential treatment and hydration. Screening is a structured safety process, not simply observing whether the patient can speak or swallow a single unsupervised sip.
Apply it
An alert patient with new stroke symptoms asks for water before taking oral tablets. Complete the approved swallowing screen first and arrange an appropriate medication route if screening cannot be passed, rather than using alertness as evidence of safe swallowing.
Common pitfall: A clear voice or strong request for water does not establish safe swallowing. Oral medications count as oral intake and require the same safety consideration.
46.Why can swallowing safety require reassessment after an initial pass?
A swallowing screen describes function under the conditions present when it was performed. Neurological deterioration, reduced alertness or new swallowing concerns can invalidate earlier reassurance. Aspiration may occur without an obvious cough, so absence of coughing is not a complete safety test. Patients with suspected dysphagia need further swallowing assessment and, when indicated, instrumental evaluation. Reassessment should follow a meaningful clinical change rather than relying indefinitely on a previous screening result.
Apply it
A patient passed screening earlier but later becomes drowsy and develops difficulty managing secretions. Pause oral intake, reassess the change and arrange further swallowing evaluation instead of continuing meals because the morning documentation recorded a pass.
Common pitfall: Treating a screening result as permanent ignores changing neurological function. Absence of coughing also cannot reliably exclude aspiration in a patient with concerning swallowing findings.
47.Why does oral hygiene matter when a patient is nil by mouth?
Oral bacteria and secretions remain present when food and drink are withheld. If contaminated material is aspirated, poor oral health can contribute to respiratory complications. Regular, supported oral hygiene is therefore part of stroke care for patients with dysphagia as well as those eating normally. Assess the patient’s ability to perform care, provide assistance and use an approach consistent with swallowing safety. Nil-by-mouth status does not eliminate the need for mouth care.
Apply it
A dysphagic patient receiving tube feeding has a dry mouth and cannot clean their teeth independently. Include assisted oral hygiene in the care plan, using the appropriate safety technique rather than assuming tube feeding makes mouth care unnecessary.
Common pitfall: Withholding food does not remove oral secretions or bacterial burden. Mouth care remains necessary, but the method must avoid introducing avoidable fluid or aspiration risk.
48.Which mechanical intervention helps prevent venous thromboembolism?
Reduced mobility after stroke promotes venous stasis and increases deep-vein thrombosis risk. Intermittent pneumatic compression is an evidence-supported mechanical option for appropriate immobile patients. Graduated compression stockings are not an equivalent evidence-based substitute in this setting. Mechanical prevention requires correct application, checks of skin and device function, and reassessment as mobility changes. Decisions about pharmacological prophylaxis additionally depend on bleeding risk, stroke type and the patient’s clinical circumstances.
Apply it
An immobile patient has a high bleeding risk that complicates immediate pharmacological prophylaxis. Apply the ordered intermittent pneumatic compression correctly and monitor skin and device use, rather than replacing it with stockings on the assumption that all compression methods are equivalent.
Common pitfall: A prescribed device provides little benefit when disconnected or removed for long periods. Stockings and pneumatic compression should not be treated as interchangeable interventions.
Inpatient Prevention and Management of Complications Following Stroke
49.How should fever after stroke be evaluated?
Fever after stroke warrants temperature management and assessment for its cause, including infection when clinically suspected. Respiratory symptoms, urinary findings, devices and the broader examination help direct investigation. Fever should not automatically be labelled a central response to brain injury, nor should it trigger antibiotics without appropriate assessment. Monitor neurological and physiological effects while communicating the pattern and associated findings. Identifying a treatable source matters alongside lowering the temperature itself.
Apply it
A stroke patient develops fever with new cough and reduced oxygen saturation. Escalate assessment for a respiratory complication and obtain indicated investigations while managing temperature, instead of recording the fever as an expected neurological consequence without evaluating its source.
Common pitfall: Treating the temperature alone can leave an infection unrecognised. Conversely, fever by itself does not establish a bacterial diagnosis or justify an indiscriminate antibiotic choice.
Inpatient Prevention and Management of Complications Following Stroke
50.How should nutrition and hydration be planned when swallowing is unsafe?
An unsafe swallow requires a plan for hydration, nutrition and medication delivery while further assessment proceeds. Withholding oral intake is an immediate safety action, not a complete long-term management strategy. Assess nutritional risk and involve the appropriate swallowing, dietetic and medical professionals to select a suitable route and monitoring plan. Enteral feeding may support intake when oral swallowing is unsafe, but it does not eliminate aspiration of secretions or the need for oral care.
Apply it
A patient repeatedly fails swallowing assessment and has received little nutrition or fluid. Prompt interdisciplinary planning for an appropriate alternative route and monitoring instead of allowing nil-by-mouth status to continue without a documented hydration and nutrition strategy.
Common pitfall: Equating aspiration prevention with simply withholding food overlooks dehydration and malnutrition. A feeding tube supports intake but does not make airway protection or oral hygiene irrelevant.
Research Support for Acute Neurovascular Practice9%
51.How is absolute risk reduction calculated?
Absolute risk reduction is the control event risk minus the treatment event risk for the same outcome and follow-up period. It expresses the difference in percentage points, making the size of benefit interpretable against the baseline risk. If events occur in 12% of controls and 8% of treated participants, the absolute reduction is four percentage points. Always specify whether the measured event is desirable or undesirable and confirm comparable denominators and follow-up.
Apply it
In an invented trial, 60 of 500 controls and 40 of 500 treated participants experience recurrent stroke. Calculate risks of 12% and 8%, then report an absolute reduction of four percentage points over the trial’s stated follow-up.
Common pitfall: Subtracting event counts without accounting for group sizes can mislead. Calling the reduction 4% without clarifying percentage points also invites confusion with a relative effect.
52.Why can relative risk reduction make a benefit look larger?
Relative risk reduction divides the absolute reduction by the control risk. A fall from 12% to 8% gives a four-percentage-point absolute reduction and a relative reduction of about 33.3%. The relative measure is valid but omits the starting risk when presented alone. Similar relative effects can yield very different absolute benefits in populations with different baseline risks. Interpret relative and absolute results together before applying evidence to an individual patient.
Apply it
A report advertises a 50% relative reduction in an adverse event. Check the actual event rates: a change from 2% to 1% means a one-percentage-point absolute reduction, which is essential context for discussing benefit and harm.
Common pitfall: A large relative percentage does not reveal how many patients benefit. Avoid interpreting “50% lower risk” as meaning that half of all treated patients avoid an event.
53.How is number needed to treat derived and bounded?
Number needed to treat is 1 divided by the absolute risk reduction expressed as a proportion. With an absolute reduction of 0.04, NNT is 25. Round a noninteger result upward to the next whole patient: 1/0.03 = 33.33, reported as 34. NNT estimates how many comparable patients require treatment to prevent one additional specified adverse event over the stated follow-up. It is an average rather than a guarantee. Baseline risk, confidence intervals, treatment harms and follow-up length affect interpretation.
Apply it
An invented study reports a four-percentage-point reduction in recurrent stroke over two years. Convert four percentage points to 0.04 and calculate 1/0.04 = 25 patients treated for two years per additional event prevented on average. No rounding changes this whole-number result.
Common pitfall: Using four instead of 0.04 gives the wrong reciprocal. Rounding a noninteger NNT downward overstates benefit, and omitting the outcome or time horizon removes essential interpretive context.
Clinical Studies Section of Labeling for Human Prescription Drug and Biological Products — Content and Format · Chapter 15: Interpreting results and drawing conclusions | Cochrane
54.How does randomisation address confounding?
Random allocation makes treatment assignment independent of participant characteristics in expectation, reducing systematic differences in known and unknown prognostic factors. Confounding occurs when another factor influences both treatment exposure and the outcome, creating a misleading association. Randomisation reduces this threat but does not guarantee identical groups, eliminate missing-data bias or correct poor outcome measurement. In observational evidence, consider why patients received one treatment and whether that reason also predicts their prognosis.
Apply it
An observational study finds worse outcomes among patients given an intensive treatment, but those patients were initially much sicker. Identify baseline severity as a potential confounder before concluding that the treatment caused the poorer outcomes.
Common pitfall: Calling any study with two groups randomised is incorrect. Random allocation concerns how treatment was assigned, while blinding and statistical adjustment address different methodological issues.
Evidence-Based Review System for the Scientific Evaluation of Health Claims
55.Why must composite endpoints be unpacked?
A composite endpoint combines several outcomes into one measure, such as death, recurrent stroke or hospital admission. A favourable composite can be driven mainly by a frequent, less severe component while the most consequential outcomes change little. Examine the component definitions, frequency and direction of effect, alongside the overall result. The clinical meaning depends on what improved, not merely whether the combined endpoint reached statistical significance. Components may also differ in objectivity and importance to patients.
Apply it
A trial reports improvement in a composite of death, stroke and admission, but almost all the difference comes from fewer admissions. Describe that specific benefit and review death and stroke separately rather than claiming the trial demonstrated a mortality reduction.
Common pitfall: Treating a composite benefit as proof that every component improved overstates the evidence. A significant combined result does not establish significance for each component.
Stroke Systems of Care7.5%
56.How does prehospital notification improve stroke readiness?
Prehospital notification allows a receiving service to prepare the stroke team, imaging and immediate assessment before arrival. Useful information includes suspected stroke findings, last-known-well and discovery times, glucose, relevant medications and estimated arrival. Notification shortens avoidable coordination delays but does not establish the final diagnosis or treatment eligibility. The purpose is to make time-critical resources ready while preserving accurate information for the receiving clinicians’ assessment and decisions.
Apply it
An ambulance team identifies a possible acute stroke and communicates the neurological findings, confirmed last-known-well, glucose and arrival estimate. The receiving service prepares imaging and the stroke response while planning to verify the history on arrival.
Common pitfall: A vague message saying only “possible stroke” limits preparation. Notification also should not convert an uncertain onset history into a falsely precise treatment timeline.
Pre-hospital Triage and Transport Guidelines for Adult Stroke in British Columbia
57.Why do stroke destination decisions depend on regional pathways?
Transport decisions balance rapid access to initial stroke treatment with access to specialised services such as thrombectomy. Geography, travel time, centre capabilities and regional agreements influence the appropriate destination. A rule designed for one province cannot be assumed to apply universally. Nurses should understand the capabilities and transfer arrangements of their own network, recognise when specialised evaluation is needed and communicate early rather than improvising a destination rule from an unrelated region.
Apply it
A rural service evaluates a possible large-vessel occlusion. Use the established regional triage and consultation pathway to coordinate destination or transfer, considering available reperfusion services and transport conditions rather than applying a city-specific bypass rule from another jurisdiction.
Common pitfall: The nearest hospital and the most specialised hospital are not interchangeable choices in every setting. Destination decisions require the applicable network pathway and current operational information.
Pre-hospital Triage and Transport Guidelines for Adult Stroke in British Columbia
58.What makes organised stroke unit care distinctive?
An organised stroke unit brings together clinicians with stroke expertise, coordinated monitoring, complication prevention, rehabilitation assessment and discharge planning. Its benefit comes from a structured interdisciplinary service rather than the bed’s physical location alone. Nursing observations connect acute treatment with swallowing safety, mobility, communication and prevention needs. Shared goals and regular team communication help identify gaps early and ensure that interventions address the patient’s changing neurological and functional condition.
Apply it
A patient is medically stable after initial treatment but has dysphagia, weakness and communication difficulty. Coordinate nursing, swallowing, rehabilitation and medical input through the stroke team instead of managing each problem as an unrelated referral without shared priorities.
Common pitfall: Labelling a ward bed as a stroke bed does not create organised stroke care. Expertise, coordinated processes and interdisciplinary review are central features of the service.
59.Which information must remain intact during stroke transfer?
A stroke transfer handoff should preserve the timeline, neurological baseline and changes, imaging findings, medication exposure and treatments already given. The receiving team needs to distinguish confirmed facts from uncertainty and know whether the patient has deteriorated during preparation. Communicate treatment times and relevant blood pressure or airway concerns, and ensure images and records are accessible. A coherent handoff prevents duplicated work, missed contraindications and avoidable interruption of a time-sensitive treatment pathway.
Apply it
A patient transfers for thrombectomy after intravenous treatment. Include last-known-well, discovery time, drug and administration details, current examination, pressure trend and imaging access information, then communicate any new deterioration directly rather than relying only on the original referral note.
Common pitfall: Copying the initial assessment without updating the current condition can conceal deterioration. Sending a scan report without accessible images may also delay the receiving team’s decisions.
Emergency Department Evaluation and Management of Patients with Transient Ischemic Attack and Acute Stroke · Pre-hospital Triage and Transport Guidelines for Adult Stroke in British Columbia
60.How can a stroke service turn a care gap into improvement?
A useful improvement measure identifies a defined care process, an eligible patient group and a reliable way to determine whether care occurred. For example, reviewing swallowing screening before first oral intake can expose a preventable safety gap. Examine why failures occur, agree on a practical workflow change and reassess the same process. Counting documentation alone may miss whether the action happened at the required time, so link records to the actual clinical sequence.
Apply it
A stroke unit finds several screens documented only after the first oral medication. Review medication and screening timestamps, identify workflow barriers and introduce a clear intake checkpoint, then repeat the review using the same eligibility and timing definitions.
Common pitfall: A higher documentation rate does not prove safer care if screening still follows oral intake. Define the clinical sequence before interpreting the improvement measure.
Acute Stroke Unit Care · Swallowing (Dysphagia), Nutrition and Oral Care
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give greatest study time to assessment and diagnosis, which together account for 36.5% of the official blueprint.
- Practise NIH Stroke Scale technique while separately recognising functional disability and meaningful component changes.
- Explain what noncontrast CT, angiography, diffusion MRI and advanced tissue imaging each establish and what each can miss.
- Connect reperfusion decisions to disabling deficits, accurate timing, medication history and treatment-specific imaging criteria.
- Contrast embolism, local thrombosis, deep arteriopathy, cerebral amyloid angiopathy and vascular malformations.
- Match secondary prevention to mechanism and make swallowing, venous thromboembolism and fever decisions concrete.
- Calculate absolute and relative effects, critique confounding and unpack composite outcomes.
- Rehearse notification, transfer handoffs and coordinated stroke unit care within the applicable regional network.
A practical preparation plan
1. Map study time to the official outline
Use all eight official domains as the study framework. Begin with assessment and diagnosis, then distribute remaining sessions across management, pathophysiology, prevention, complications, research and systems using the published weights.
2. Build assessment-to-diagnosis cases
For each case, establish last-known-well, glucose, precise neurological findings and functional consequences. Choose the next imaging question and explain why a normal CT or early negative MRI may not resolve the diagnosis.
3. Rehearse treatment boundaries
Compare disabling and nondisabling deficits, standard and imaging-selected pathways, thrombolytic and endovascular assessment, and ischaemic versus haemorrhagic blood pressure principles. State the decisive cue before naming an action.
4. Link mechanism with ongoing care
For each stroke mechanism, specify the prevention strategy and important bleeding considerations. Add swallowing, hydration, nutrition, oral hygiene, mobility-related thrombosis prevention and fever assessment to the same patient’s care plan.
5. Use drills to diagnose learning gaps
Answer the 20 questions before viewing explanations. For each error, identify the missed cue and explain why every alternative is less suitable. Use the flashcards for spaced recall; these small sets do not predict examination performance.
6. Finish with evidence and communication
Calculate risk measures from invented trial data, inspect composite endpoints and identify possible confounding. Practise a concise stroke handoff that preserves timing, uncertainty, current findings, imaging and treatment details.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- Certification for Neurovascular Registered Nurse (NVRN-BC)
- NVC-3
- NVRN Exam Blueprint
- NIH Stroke Scale
- Emergency Department Evaluation and Management of Patients with Transient Ischemic Attack and Acute Stroke
- National Clinical Guideline for Stroke: Acute Care
- Stroke Diagnosis — NHLBI
- Stroke Causes and Risk Factors — NHLBI
- Stroke — NIH Health
- Top Things to Know: 2026 Guideline for the Early Management of Patients With AIS
- Top Things to Know: 2022 Spontaneous Intracerebral Hemorrhage Guideline
- Top Things to Know: 2021 Secondary Stroke Prevention Guideline
- Swallowing (Dysphagia), Nutrition and Oral Care
- Inpatient Prevention and Management of Complications Following Stroke
- Acute Stroke Unit Care
- Pre-hospital Triage and Transport Guidelines for Adult Stroke in British Columbia
- Clinical Studies Section of Labeling for Human Prescription Drug and Biological Products — Content and Format
- Evidence-Based Review System for the Scientific Evaluation of Health Claims
- 6. Antiplatelet Therapy for Ischemic Stroke and Transient Ischemic Attack | Canadian Stroke Best Practices
- 103172s5259lbl.pdf
- 103909s5197lbl.pdf
- 202155s021lbl.pdf
- Chapter 15: Interpreting results and drawing conclusions | Cochrane
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.